Correction to “Modulating Neuroinflammation and Cognitive Function in Postoperative Cognitive Dysfunction via CCR5-GPCRs-Ras-MAPK Pathway Targeting With Microglial EVs”

IF 4.8 1区医学 Q1 NEUROSCIENCES

CNS Neuroscience & Therapeutics Pub Date : 2024-09-27 DOI:10.1111/cns.70063

引用次数: 0

Abstract

Qi Z., Peng J., Wang H., et al., “Modulating Neuroinflammation and Cognitive Function in Postoperative Cognitive Dysfunction via CCR5-GPCRs-Ras-MAPK Pathway Targeting With Microglial EVs,” CNS Neuroscience and Therapeutics 2024;30: e14924, https://doi.org/10.1111/cns.14924.

The funding number 81971020 in the Funding Information section is incorrect. This should be read as National Natural Science Foundation of China, Grant/Award Number: 82201331.

We apologize for this error.

查看原文本刊更多论文

对 "通过小胶质细胞 EV 靶向 CCR5-GPCRs-Ras-MAPK 通路调节术后认知功能障碍中的神经炎症和认知功能 "的更正

Qi Z., Peng J., Wang H., et al., "Modulating Neuroinflammation and Cognitive Function in Postoperative Cognitive Dysfunction via CCR5-GPCRs-Ras-MAPK Pathway Targeting With Microglial EVs," CNS Neuroscience and Therapeutics 2024;30: e14924, https://doi.org/10.1111/cns.14924.The Funding Information 部分中的基金编号 81971020 有误。我们对此表示歉意。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

CNS Neuroscience & Therapeutics 医学-神经科学

CiteScore

7.30

自引率

12.70%

发文量

240

审稿时长

2 months

期刊介绍： CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.